Browsing: Sanofi

SHANGHAI (Reuters) -Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in…

Investing.com — Sanofi (EPA:)(NASDAQ:) has entered into exclusive negotiations with private equity firm Clayton, Dubilier & Rice to sell a…

By Michael Erman NEW YORK (Reuters) -Sanofi’s chief executive, Paul Hudson (NYSE:), said in an interview on Monday that the…

By Ludwig Burger (Reuters) – Sanofi (NASDAQ:)’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of…

Fulcrum Therapeutics (ticker: NASDAQ:) has entered into a significant collaboration with Sanofi (NASDAQ:) for the development and commercialization of losmapimod,…

Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid vaccine…

Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did not disclose the…